Live Updates: COVID-19 Cases
  • World 30,906,084
    World
    Confirmed: 30,906,084
    Active: 7,439,103
    Recovered: 22,507,351
    Death: 959,630
  • USA 6,958,427
    USA
    Confirmed: 6,958,427
    Active: 2,545,861
    Recovered: 4,208,887
    Death: 203,679
  • India 5,392,645
    India
    Confirmed: 5,392,645
    Active: 1,009,995
    Recovered: 4,295,946
    Death: 86,704
  • Brazil 4,503,002
    Brazil
    Confirmed: 4,503,002
    Active: 577,828
    Recovered: 3,789,139
    Death: 136,035
  • Russia 1,097,251
    Russia
    Confirmed: 1,097,251
    Active: 171,450
    Recovered: 906,462
    Death: 19,339
  • Peru 756,412
    Peru
    Confirmed: 756,412
    Active: 124,334
    Recovered: 600,795
    Death: 31,283
  • Mexico 688,954
    Mexico
    Confirmed: 688,954
    Active: 123,959
    Recovered: 492,192
    Death: 72,803
  • South Africa 659,656
    South Africa
    Confirmed: 659,656
    Active: 54,282
    Recovered: 589,434
    Death: 15,940
  • Spain 659,334
    Spain
    Confirmed: 659,334
    Active: 628,839
    Recovered: ?
    Death: 30,495
  • Chile 444,674
    Chile
    Confirmed: 444,674
    Active: 14,319
    Recovered: 418,101
    Death: 12,254
  • France 442,194
    France
    Confirmed: 442,194
    Active: 319,346
    Recovered: 91,574
    Death: 31,274
  • Iran 419,043
    Iran
    Confirmed: 419,043
    Active: 37,293
    Recovered: 357,632
    Death: 24,118
  • UK 390,358
    UK
    Confirmed: 390,358
    Active: 348,599
    Recovered: ?
    Death: 41,759
  • Bangladesh 347,372
    Bangladesh
    Confirmed: 347,372
    Active: 88,073
    Recovered: 254,386
    Death: 4,913
  • Saudi Arabia 329,271
    Saudi Arabia
    Confirmed: 329,271
    Active: 15,383
    Recovered: 309,430
    Death: 4,458
  • Pakistan 305,031
    Pakistan
    Confirmed: 305,031
    Active: 6,572
    Recovered: 292,044
    Death: 6,415
  • Turkey 301,348
    Turkey
    Confirmed: 301,348
    Active: 27,786
    Recovered: 266,117
    Death: 7,445
  • Italy 296,569
    Italy
    Confirmed: 296,569
    Active: 43,161
    Recovered: 217,716
    Death: 35,692
  • Germany 272,080
    Germany
    Confirmed: 272,080
    Active: 19,614
    Recovered: 243,000
    Death: 9,466
  • Canada 142,763
    Canada
    Confirmed: 142,763
    Active: 9,368
    Recovered: 124,184
    Death: 9,211
  • Netherlands 91,934
    Netherlands
    Confirmed: 91,934
    Active: 85,659
    Recovered: ?
    Death: 6,275
  • China 85,269
    China
    Confirmed: 85,269
    Active: 171
    Recovered: 80,464
    Death: 4,634
  • Australia 26,885
    Australia
    Confirmed: 26,885
    Active: 2,079
    Recovered: 23,962
    Death: 844
  • S. Korea 22,893
    S. Korea
    Confirmed: 22,893
    Active: 2,545
    Recovered: 19,970
    Death: 378
  • New Zealand 1,811
    New Zealand
    Confirmed: 1,811
    Active: 67
    Recovered: 1,719
    Death: 25

Vaccine trial: Vital signs of volunteers normal, says doctor

Author at TechGenyz Health
Vaccine Phase-II
A picture of a COVID-19 vaccine in a artistic wasy credit: @Pete Linforth |Pixabay

Vital health parameters of the two volunteers, who have been administered the Oxford COVID-19 vaccine candidate at a medical college here as part of phase II clinical trial, are normal, a senior official from the medical facility said on Thursday.

Two men, aged 32 and 48, were given the first shot of the ‘Covishield’ vaccine, being manufactured by Pune-based Serum Institute of India (SII), at Bharti Vidyapeeth’s Medical College and Hospital on Wednesday. The dose will be repeated after one month, an official said.

Since yesterday, our medical team is in touch with the two volunteers and both are fine. They do not have any pain, fever, injection-side reaction or systemic illness post-vaccination.- Dr. Jitendra Oswal the medical college and hospital’s deputy medical director.

After the vaccine was administered on Wednesday, both the volunteers were observed for 30 minutes and later allowed to go home, he said.

“They have been given all the necessary emergency numbers (to contact in case of need) and our medical team is also conducting follow-ups with them,” he added.

The vaccine dose will be repeated on both the volunteers after one month, the hospital’s medical director Dr. Sanjay Lalwani said on Wednesday.

He said in all, 25 candidates will be given the vaccine in the next seven days.

Dr. Sonali Palkar, in-charge of the medical college’s research cell, said four to five persons were screened on Wednesday and a decision to administer the vaccine to them as part of the clinical trial is subject to their COVID-19 and antibody test reports.

SII, the world’s largest vaccine maker has signed an agreement to manufacture the potential vaccine developed by the Jenner Institute of Oxford University in collaboration with British-Swedish pharma company AstraZeneca.

Career

Subscribe